- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Syndax Pharmaceuticals
Total 19572 results
-
Synta Pharmaceuticals Corp.CompletedCrohn's DiseaseUnited States, Canada
-
Synta Pharmaceuticals Corp.CompletedSoft Tissue SarcomaUnited States, Canada
-
Synta Pharmaceuticals Corp.Completed
-
Synta Pharmaceuticals Corp.CompletedGastrointestinal Stromal TumorUnited States
-
Synta Pharmaceuticals Corp.CompletedBreast Cancer | Triple Negative Breast Cancer | HER-2 Positive Breast Cancer | ER/Progressive Response (PR) + Refractory to Prior Hormonal TreatmentSpain, United States, Argentina, Belgium, Brazil, Korea, Republic of, Peru, United Kingdom
-
Synta Pharmaceuticals Corp.CompletedSolid Tumor MalignanciesUnited States
-
Synta Pharmaceuticals Corp.CompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | AML | CML | ALL | Blast-phase Chronic Myelogenous LeukemiaUnited States
-
Synta Pharmaceuticals Corp.UnknownSolid TumorsUnited States
-
Synta Pharmaceuticals Corp.CompletedMyeloproliferative Disorders | AML | MDS | CMLUnited States
-
Synta Pharmaceuticals Corp.Completed
-
Synta Pharmaceuticals Corp.CompletedStage IIIB Non-Small Cell Lung Cancer | Stage IV Non-Small Cell Lung CancerUnited States
-
Maximilian Stahl, MDSyndax PharmaceuticalsNot yet recruitingAcute Myeloid Leukemia | Leukemia | AML | AML, Adult | AML With Gene MutationsUnited States
-
Abramson Cancer Center of the University of PennsylvaniaSyndax PharmaceuticalsWithdrawn
-
Vastra Gotaland RegionMerck Sharp & Dohme LLC; Syndax PharmaceuticalsCompletedMetastatic Uveal MelanomaSweden
-
Georgetown UniversitySynta Pharmaceuticals Corp.TerminatedCancer | Small Cell Lung CancerUnited States
-
Emory UniversitySynta Pharmaceuticals Corp.TerminatedStage IVA Oral Cavity Squamous Cell Carcinoma | Stage IVA Laryngeal Squamous Cell Carcinoma | Stage IVA Oropharyngeal Squamous Cell Carcinoma | Stage I Hypopharyngeal Squamous Cell Carcinoma | Stage I Laryngeal Squamous Cell Carcinoma | Stage I Oropharyngeal Squamous Cell Carcinoma | Stage II... and other conditionsUnited States
-
Emory UniversitySynta Pharmaceuticals Corp.CompletedRectal CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLC; Syndax PharmaceuticalsActive, not recruitingBladder CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); Syndax PharmaceuticalsTerminatedBreast Cancer | Invasive Breast Cancer | ER-Negative PR-Negative HER2-Negative Breast CancerUnited States
-
M.D. Anderson Cancer CenterAbbVie; Syndax Pharmaceuticals; Break Through CancerNot yet recruiting
-
Sidney Kimmel Comprehensive Cancer Center at Johns...AstraZeneca; Syndax PharmaceuticalsCompletedUnresectable Intrahepatic CholangiocarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLC; Syndax PharmaceuticalsActive, not recruitingLymphoma | Refractory | RelapsedUnited States
-
Dana-Farber Cancer InstituteSynta Pharmaceuticals Corp.TerminatedMelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterSynta Pharmaceuticals Corp.Completed
-
Memorial Sloan Kettering Cancer CenterSynta Pharmaceuticals Corp.Completed
-
Roberto PiliBristol-Myers Squibb; Syndax Pharmaceuticals; Indiana University School of MedicineActive, not recruitingRenal Cell CarcinomaUnited States
-
IRCCS SYNLAB SDNRecruitingSubjects Undergoing Diagnostic Imaging TestsItaly
-
IRCCS SYNLAB SDNCompleted
-
Emory UniversitySynta Pharmaceuticals Corp.; Multiple Myeloma Research ConsortiumCompletedMultiple MyelomaUnited States
-
IRCCS SYNLAB SDNRecruiting
-
IRCCS SYNLAB SDNRecruitingPatients With Frontal and Parietal Lobe DysfunctionItaly
-
IRCCS SYNLAB SDNCompletedPatients With Ischemic or Idiopathic Dilated CardiomyopathyItaly
-
Novartis PharmaceuticalsChugai PharmaceuticalCompletedPostmenopausal Women With Advanced Breast CancerJapan
-
Novartis PharmaceuticalsChugai PharmaceuticalCompletedPostmenopausal Women With Advanced Breast CancerJapan
-
Novartis PharmaceuticalsChugai PharmaceuticalCompletedPostmenopausal Women With Advanced Breast CancerJapan
-
Roberto PiliSyndax Pharmaceuticals; Clinigen, Inc.; Indiana University Melvin and Bren Simon...Active, not recruiting
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; National Cancer Institute (NCI); Syndax PharmaceuticalsCompletedPancreatic Cancer | Cholangiocarcinoma | Metastatic Pancreatic Cancer | Unresectable Pancreatic Cancer | Metastatic Cholangiocarcinoma | Unresectable CholangiocarcinomaUnited States
-
Synerx Pharma, LLCCompleted
-
Synlab Holding Deutschland GmbHCompletedCOVAG - Covid-19 Antigen Study - the Diagnostic Efficacy of SARS-CoV-2 Rapid Detection Tests (COVAG)COVID-19 | SARS-CoV2 Infection | SARS (Disease)Germany
-
ID3 MedicalCyndRx, LLCCompleted
-
Novartis PharmaceuticalsPharmaceutical Research AssociatesWithdrawn
-
Novartis PharmaceuticalsPharmaceutical Research AssociatesWithdrawn
-
Regeneron PharmaceuticalsTeva Pharmaceutical Industries, Ltd.CompletedOsteoarthritis, Knee | Osteoarthritis, HipUnited States
-
Enanta Pharmaceuticals, IncPharmaceutical Research AssociatesCompletedChronic HBV InfectionHong Kong, Taiwan
-
Regeneron PharmaceuticalsTeva Pharmaceutical Industries, Ltd.TerminatedOsteoarthritis | Chronic Low Back PainUnited States
-
Enanta Pharmaceuticals, IncPharmaceutical Research AssociatesCompletedRSV InfectionUnited States
-
Melior PharmaceuticalsBukwang Pharmaceutical, Co., Ltd.Completed
-
Tibotec Pharmaceuticals, IrelandTibotec Pharmaceutical LimitedCompletedHuman Immunodeficiency Virus 1South Africa, Argentina, Brazil, India, Kenya
-
Vertex Pharmaceuticals IncorporatedTibotec Pharmaceutical LimitedCompleted
-
Regeneron PharmaceuticalsTeva Pharmaceutical Industries, Ltd.TerminatedOsteoarthritis, Knee | Osteoarthritis, HipUnited States, Poland, United Kingdom